To evaluate the potency of curcumin to inhibit medulloblastoma growth in vivo, we used two independent mouse models: subcutaneous DAOY xenografts and the Smo/Smo transgenic medulloblastoma model. The gene discussed is SMO; the disease is medulloblastoma.